Physician profile
Rowena G Baumgartner
NPI 1811972052
$794.60
in general payments reported to CMS, 2019-2025
18 companies · $66.69 in 2025
The $66.69 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2021: $30.00 · 2023: $123 · 2024: $97.87 · 2025: $66.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $184.98 | 2019 | |
| Abbvie INC. | $119.22 | 2019 | |
| Corium, LLC | $108.96 | 2023-2024 | Azstarys |
| Sanofi Pasteur INC. | $54.01 | 2019-2025 | |
| Glaxosmithkline, LLC. | $44.08 | 2021-2025 | Bexsero |
| Alk-Abello, INC | $43.60 | 2023 | Grastek, Ragwitek, Odactra |
| Kaleo, INC. | $43.59 | 2019 | |
| Sobi, INC | $28.45 | 2019 | |
| Arbor Pharmaceuticals, INC. | $25.06 | 2019 | |
| Cranial Technologies, INC | $22.52 | 2024 | Doc Band |
| Shire North American Group INC | $17.77 | 2019 | |
| Boston Scientific Corporation | $17.03 | 2024 | Watchman |
| Kowa Pharmaceuticals America, INC. | $16.76 | 2025 | Zoryve |
| Acadia Pharmaceuticals INC | $15.64 | 2025 | Daybue |
| Supernus Pharmaceuticals, INC. | $15.11 | 2024 | Qelbree |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $13.27 | 2019 | |
| Merck Sharp & Dohme LLC | $12.58 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rowena Baumgartner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.